Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/1992
02/19/1992CN1058778A 吲哚衍生物 Indole derivatives
02/19/1992CN1058775A Sulphurous derivatives of imidazole, their preparation process, intermediates obtained, their use as medicaments and pharmaceutical compositions containing them
02/19/1992CN1058773A (bemzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma
02/19/1992CN1058771A Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflamatory agents
02/19/1992CN1058717A Antiperiodic-sagebrush methyl ether compound and its made process
02/19/1992CN1015545B Hydroxy-ethanoic acid derivative for treating complication of diabets mellitus
02/18/1992US5089657 Topical antiinflammatory agents
02/18/1992US5089523 Fluorinated derivatives of mevinic acids
02/18/1992US5089513 Antiinflammatory agents; antiallergens; asthma; side effect reduction
02/18/1992US5089504 Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
02/18/1992US5089496 Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
02/18/1992US5089495 Lipoxygenase inhibitors
02/18/1992US5089489 6-substituted penem esters as anti-inflammatory and anti-degenerative agents
02/18/1992US5089471 Renin inhibitors
02/18/1992CA1296013C Process for preparing novel n-(acyloxyalkoxy) carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
02/18/1992CA1296011C ¬(phenyl-sulphamoyl or sulphonamido)- 1,2,3,4-tetrahydroisoquinoline-2-yl| alkyl acid
02/18/1992CA1296009C ¬(2-imidozol-l-yl ethylthio|-benzoic acid derivative
02/18/1992CA1296005C Inhibition of the 5-lipoxygenase pathway
02/18/1992CA1296004C Aza-indole derivatives
02/18/1992CA1295998C Nucleosides and their use as antineoplastic agents
02/16/1992WO1992003429A1 Renin inhibitors
02/16/1992WO1992003423A1 Benzimidazole derivatives, process for their preparation and application
02/16/1992WO1992003413A1 Diphenylurea derivatives
02/16/1992WO1992003134A1 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole
02/16/1992CA2089268A1 Renin inhibitors
02/16/1992CA2089165A1 Diphenylurea derivatives
02/16/1992CA2088775A1 Pharmaceutical formulations of 5- (2-chloro-1-hydroxyethyl)-4-methylthiazole
02/15/1992WO1992003125A1 Bone growth stimulator
02/14/1992WO1992003476A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
02/14/1992WO1992003408A1 Benzanilide derivatives and their use as anti-antherosclerotic agents
02/14/1992WO1992003129A1 Methods for inducing cell differentiation using ceramides
02/14/1992CA2089166A1 Benzanilide derivatives and their use as anti-antherosclerotic agents
02/14/1992CA2089001A1 Methods for inducing cell differentiation using ceramides
02/14/1992CA2088972A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
02/13/1992DE4024885A1 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one
02/12/1992EP0470805A1 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
02/12/1992EP0470686A2 (Benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma
02/12/1992EP0470543A1 Heterocyclic imidazoles, remedies containing them and processes for their preparation
02/12/1992EP0470431A2 Use of fosfomycin pharmaceutically acceptable salts as a topical cicatrizer
02/12/1992EP0470251A1 Liquid prostaglandin composition
02/12/1992EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin
02/12/1992EP0470117A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions.
02/12/1992CN1058597A Process for enzymatic preparation of basic fibroblast growth factor
02/12/1992CN1058594A Imidazo (4,5-c) pyridines as antiosteoporotic agents
02/12/1992CN1015457B 5-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine
02/12/1992CN1015452B Process for preparing butenoic acid amide compounds
02/11/1992US5087614 Inhibits aspartic proteinases
02/11/1992US5087453 Method for the treatment of bacterial caused weight loss and/or hypoglycemia
02/11/1992CA2048810A1 Method for treatment of bone wasting diseases
02/11/1992CA2048809A1 Heterocyclic imidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
02/10/1992CA2047249A1 Process
02/10/1992CA2038066A1 (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma
02/09/1992WO1992002217A1 Antimalarial compositions
02/09/1992CA2048518A1 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
02/07/1992WO1992002235A1 Calcium and trace mineral supplements
02/06/1992WO1992001697A1 Novel substituted thiazolyl and substituted pyridinyl derivatives
02/06/1992WO1992001675A2 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions
02/06/1992WO1992001670A1 Excitatory amino acid antagonists
02/06/1992WO1992001452A1 Enzyme inactivators
02/06/1992WO1992000011A3 Leukotriene b4 antagonists
02/06/1992CA2086546A1 Novel substituted thiazolyl and substituted pyridinyl derivatives
02/05/1992EP0469889A1 (p-Carbonylaminophenyl)-sulphonyl-nitromethane derivatives
02/05/1992EP0469888A1 Amidobenzenes
02/05/1992EP0469887A1 Acetamide derivatives
02/05/1992EP0469837A2 Use of a compound in the manufactur of a medicament for lowering of blood uric acid levels
02/05/1992EP0469833A1 N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them
02/05/1992EP0469813A2 Use of zwitterionic compounds and their N-halo derivatives
02/05/1992EP0469548A2 4-Amino-delta4-steroids and their use as 5alpha-reductase inhibitors
02/05/1992EP0469477A1 Antiallergic combination
02/05/1992EP0338010B1 Pharmaceutical compositions for treatment of hyperproliferate skin disease
02/05/1992CN1058406A Substituted azole, process for production and use thereof
02/05/1992CN1058404A Derivatives of benzimidazole, their preparation, and their use as medicaments
02/05/1992CN1058397A Derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments
02/05/1992CN1058396A Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase a2 inhibitor containing them
02/05/1992CN1058341A Composition and method for topical treatment of damaged or diseased tissue
02/04/1992WO1992004895A1 Enhancement of glutathione levels with glutamine
02/04/1992WO1992002245A1 Treatment of human lactation failure
02/04/1992US5086180 Sulphamoylthiophenes, a process for their preparation
02/04/1992US5086071 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives
02/04/1992US5086067 Inhibits phospholipase activity which reduces leucotriene production
02/04/1992US5086065 Leukotriene antagonists
02/04/1992US5086062 Inhibitors of lipoxygenase and-or cyclooxygenase enzymes
02/04/1992US5086050 With acetic, gluconic, lactic or malic acids, administering
02/04/1992US5086047 Controlling estrogen production; breast cancer
02/04/1992CA1295336C2 Synthetic intermediates for preparing substituted di-t-butylphenols
02/04/1992CA1295333C Acylaminoalkanoyl compounds
02/04/1992CA1295259C Process for augmenting soft tissue with cross-linked polyvinyl pyrrolidone
02/04/1992CA1295241C Lymphokine and its production and uses
02/04/1992CA1295174C Fodder additive and a process for the preparation thereof
02/03/1992CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor
02/03/1992CA2048345A1 Aniline derivatives
02/03/1992CA2048325A1 Acetamide derivatives
02/03/1992CA2048318A1 Amidobenzenes
02/03/1992CA2048236A1 Antiallergic combination
02/01/1992WO1992002545A1 Bombesin antagonists
02/01/1992WO1992002510A1 Substituted [1h-imidazol-5-yl]alkanoic acids
02/01/1992CA2088166A1 Peptides
02/01/1992CA2087840A1 Substituted ¬1h-imidazol-5-yl| alkanoic acids
02/01/1992CA2048178A1 Engineered antibodies
01/1992
01/31/1992CA2048068A1 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions